Génie Enzymatique et Cellulaire (GEC), FRE 3580 CNRS, Université de Technologie de Compiègne, France.
UMR S 1138, Sorbonne Universités, Université Pierre et Marie Curie - Paris VI, France.
FEBS J. 2017 Feb;284(4):634-653. doi: 10.1111/febs.14012. Epub 2017 Feb 6.
β-lactamase enzymes responsible for bacterial resistance to antibiotics are among the most important health threats to the human population today. Understanding the increasingly vast structural motifs responsible for the catalytic mechanism of β-lactamases will help improve the future design of new generation antibiotics and mechanism-based inhibitors of these enzymes. Here we report the construction of a large murine single chain fragment variable (scFv) phage display library of size 2.7 × 10 with extended diversity by combining different mouse models. We have used two molecularly different inhibitors of the R-TEM β-lactamase as targets for selection of catalytic antibodies with β-lactamase activity. This novel methodology has led to the isolation of five antibody fragments, which are all capable of hydrolyzing the β-lactam ring. Structural modeling of the selected scFv has revealed the presence of different motifs in each of the antibody fragments potentially responsible for their catalytic activity. Our results confirm (a) the validity of using our two target inhibitors for the in vitro selection of catalytic antibodies endowed with β-lactamase activity, and (b) the plasticity of the β-lactamase active site responsible for the wide resistance of these enzymes to clinically available inhibitors and antibiotics.
β-内酰胺酶负责细菌对抗生素的耐药性,是当今人类健康面临的最重要威胁之一。了解负责β-内酰胺酶催化机制的日益广泛的结构基序将有助于改进新一代抗生素和这些酶的基于机制抑制剂的未来设计。在这里,我们报告了构建一个大型的鼠单链片段可变(scFv)噬菌体展示文库,其大小为 2.7×10,通过结合不同的小鼠模型,扩展了多样性。我们使用两种分子上不同的 R-TEM β-内酰胺酶抑制剂作为目标,选择具有β-内酰胺酶活性的催化抗体。这种新方法导致分离出五个抗体片段,它们都能够水解β-内酰胺环。对所选 scFv 的结构建模揭示了每个抗体片段中存在不同的基序,这些基序可能负责它们的催化活性。我们的结果证实了(a)使用我们的两种靶标抑制剂在体外选择具有β-内酰胺酶活性的催化抗体的有效性,以及(b)β-内酰胺酶活性位点的可塑性,该位点负责这些酶对临床可用抑制剂和抗生素的广泛耐药性。